Microparticle structure of Lycopodium clavatum peptide fermentation product

TWM689484UActive Publication Date: 2026-11-11恆陞生技股份有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115204957
Authority / Receiving Office
TW · TW
Patent Type
Utility models
Current Assignee / Owner
Filing Date
2026-05-29
Publication Date
2026-11-11
Estimated Expiration
2036-05-28

Smart Images

  • Figure TWG2TB001921244_001
    Figure TWG2TB001921244_001
  • Figure TWG2TB001921244_002
    Figure TWG2TB001921244_002
  • Figure TWG2TB001921244_003
    Figure TWG2TB001921244_003
Patent Text Reader

Abstract

This invention provides a microparticle structure of a *Lycopodium clavatum* peptide ferment, comprising: a microparticle carrier, which is a core entity formed by structuring a *Lycopodium clavatum* peptide ferment; an exosome unit, which is a plurality of vesicles dispersed within or on the surface of the microparticle carrier; a *Lycopodium clavatum* peptide unit, which is a plurality of chain-like molecules interwoven within or on the surface of the microparticle carrier; and a protective layer having a three-dimensional closed network structure and covering the periphery of the microparticle carrier. This layered coating configuration effectively restricts the spatial displacement of the exosome unit and the *Lycopodium clavatum* peptide unit to stably lock their activity, resulting in practical effects of significantly reducing muscle cell inflammatory hormones (IL-1β, IL-6) and greatly increasing the expression of antioxidant enzymes (SOD).
Need to check novelty before this filing date? Find Prior Art

Claims

1. A microparticle structure of a *Lycopodium clavatum* peptide ferment, the microparticle structure comprising: a microparticle carrier, which is a core entity formed by structuring a *Lycopodium clavatum* peptide ferment; an exosome unit, which is a plurality of vesicles dispersed within or on the surface of the microparticle carrier; a *Lycopodium clavatum* peptide unit, which is a plurality of chain-like molecules interwoven within or on the surface of the microparticle carrier; and a protective layer having a three-dimensional closed network structure and covering the periphery of the microparticle carrier to restrict the spatial displacement of the exosome unit and the *Lycopodium clavatum* peptide unit.

2. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, wherein the detection concentration of the exosome unit in the microparticle structure is greater than 1 × 10¹² p / g.

3. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 2, wherein the detection concentration of the exosome unit in the microparticle structure is 9.5 × 10¹² p / g.

4. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, wherein the molecular weight of the *Lycopodium clavatum* peptide unit is less than 3 kDa.

5. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, wherein the mass percentage of the *Lycopodium clavatum* peptide unit in the microparticle structure is greater than 10%.

6. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 5, wherein the mass percentage of the *Lycopodium clavatum* peptide unit in the microparticle structure is 10.08%.

7. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, which has the property of reducing the expression of the inflammatory hormone IL-1β in an inflamed muscle cell by up to 40% when applied to the muscle cell.

8. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, which has the property of reducing the expression of the inflammatory hormone IL-6 in an inflamed muscle cell by up to 87% when applied to the muscle cell.

9. The microparticle structure of the *Lycopodium clavatum* peptide ferment as described in claim 1, which has the property of increasing the activity of the antioxidant enzyme SOD in a muscle cell by 72% when applied to a muscle cell under high oxidative stress.